Trial intelligence / Profile preview

Telbivudine and Lamivudine in late pregnancy to prevent HBV vertical transmission

NCT01788371Phase 4Completed

Start
Mar 2009
Primary completion
Jul 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 4 trial of telbivudine, lamivudine in hepatitis B (HBV). Started Mar 2009; status: completed.

02

Drugs

telbivudinelamivudine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01788371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01788371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call